Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Salbutamol sulfate film-controlled slow-release pellet capsule

A technology of salbutamol sulfate and sustained-release pellets, which can be used in medical preparations with non-active ingredients, respiratory diseases, organic active ingredients, etc., and can solve problems such as decreased release.

Active Publication Date: 2013-07-24
北京天衡药物研究院有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In order to solve the problem of release decline caused by film aging of salbutamol sulfate film-controlled sustained-release pellets prepared by aqueous dispersion coating, the present invention provides a film-controlled sulfuric acid film capable of maintaining stable release performance throughout the validity period. Salbutamol sustained-release pellet capsules are characterized in that the core of the pellets contains sodium carboxymethyl starch with high water-swellability, and the sustained-release coating film is deformed by water swelling, thereby offsetting the aging of the film

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Salbutamol sulfate film-controlled slow-release pellet capsule
  • Salbutamol sulfate film-controlled slow-release pellet capsule
  • Salbutamol sulfate film-controlled slow-release pellet capsule

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] The albuterol sulfate sustained-release pellet capsule of embodiment 1 common ball core

[0031] 1. Prescription

[0032] 1. Pill core prescription (1000 capsules)

[0033]

[0034]

[0035] * Calculated as albuterol is 8g

[0036] 2. Prescription of sustained-release film coating solution

[0037]

[0038] 3. No. 0 stomach-soluble gelatin capsule shell 1000 capsules

[0039] Second, the preparation process:

[0040] 1. Ball core preparation process:

[0041] (1) Take albuterol sulfate and microcrystalline cellulose PH101 of prescription quantity, put in wet granulator and mix evenly.

[0042] (2) 2% carboxymethylcellulose sodium 10% ethanol solution to make soft material;

[0043] (3) Extrude on the extruder, the screen aperture is 1.0mm, and the extrusion speed is 20-30rpm;

[0044] (4) spheronization, the spheronization speed is 900~1000rpm, drying in the fluidized bed;

[0045] (5) Sieve, and take ball cores between 16 and 30 mesh.

[0046] 2. Prepar...

Embodiment 2

[0069] Example 2 Salbutamol Sulfate Sustained-release Pellet Capsules Containing 5% Sodium Carboxymethyl Starch

[0070] 1. Prescription

[0071] 1. Pill core prescription (1000 capsules)

[0072]

[0073] 2. Prescription of sustained-release film coating solution: same as in Example 1

[0074] 3. No. 0 stomach-soluble gelatin capsule shell 1000 capsules

[0075] Second, the preparation process:

[0076] 1. Ball core preparation process:

[0077] (1) take by weighing albuterol sulfate, microcrystalline cellulose PH101, sodium carboxymethyl starch of recipe quantity, put in the wet granulator and mix homogeneously;

[0078] (2) 2% carboxymethylcellulose sodium 10% ethanol solution to make soft material;

[0079] (3) Extrude on the extruder, the screen aperture is 1.0mm, and the extrusion speed is 20-30rpm;

[0080] (4) spheronization, the spheronization speed is 900~1000rpm, drying in the fluidized bed;

[0081] (5) Sieve, and take ball cores between 16 and 30 mesh. ...

Embodiment 3

[0097] Example 3 Salbutamol Sulfate Sustained Release Pellet Capsules Containing 10% Sodium Carboxymethyl Starch

[0098] 1. Prescription

[0099] 1. Pill core prescription (1000 capsules)

[0100]

[0101] 2. Prescription of sustained-release film coating solution: same as in Example 1.

[0102] 3. No. 0 stomach-dissolving gelatin capsule shells, 1,000 capsules.

[0103] Second, the preparation process:

[0104] 1. Ball core preparation process: with embodiment 2.

[0105] 2. The preparation process of the slow-release film coating solution: the same as in Example 1.

[0106] 3. Coating (sustained release film):

[0107] The ball core is placed in a fluidized bed for coating, and the weight gain of the coating film is controlled, and the weight gain of the coating is 20.1% and 25.9%.

[0108] 4, heat treatment: with embodiment 1.

[0109] 5. Capsule filling: the coated pellets are filled into capsules.

[0110] 3. Release, content determination and results

[0111] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a salbutamol sulfate film-controlled slow-release pellet capsule. A slow-release film of the salbutamol sulfate film-controlled slow-release pellet utilizes Kollicoat SR30D as a film-formation material. A pellet core of the salbutamol sulfate film-controlled slow-release pellet contains sodium carboxymethyl starch having high expansibility, and also contains a pharmaceutically-acceptable common excipient for the slow-release pellet, wherein preferably, the excipient comprises microcrystalline cellulose, and the pellet core comprises 5 to 20wt% of the sodium carboxymethyl starch. The slow-release film comprises Kollicoat SR30D, triethyl citrate as a plasticizer and talcum powder as an antiplastering aid, wherein preferably, a ratio of Kollicoat SR30D to triethyl citrate to talcum powder is 30: 1: 4 and a film weight increasing ratio is in a range of 19 to 38%. The salbutamol sulfate film-controlled slow-release pellet comprises the pellet core containing sodium carboxymethyl starch having high water expansibility and thus after absorbing water, the salbutamol sulfate film-controlled slow-release pellet obviously expands so that the slow-release film is stretched; the thickness of the slow-release film is reduced; the water-permeable micropore size is increased; and permeability is improved and the permeability reduction caused by film aging is counteracted. Therefore, in middle and later stages, the salbutamol sulfate film-controlled slow-release pellet release rate is basically constant; in the last stage, residues are less; and stable release performances can be kept in the period of validity.

Description

technical field [0001] The invention relates to a salbutamol sulfate membrane-controlled sustained-release pellet capsule, in particular to a salbutamol sulfate membrane-controlled sustained-release pellet capsule with a pellet core containing sodium carboxymethyl starch, belonging to the field of pharmaceutical preparations. Background technique [0002] Salbutamol sulfate is a synthetic beta 2 Receptor agonist, can selectively act on bronchial smooth muscle β 2 -receptor, which has a strong bronchodilation effect, and is used for the treatment of bronchial asthma or asthmatic bronchitis and other respiratory diseases accompanied by bronchospasm. [0003] Salbutamol sulfate is dissolved in water. The salbutamol sulfate osmotic pump controlled-release tablets that are administered twice a day by MURO Company can achieve zero-order release and uniform drug release. The disadvantage is that the semipermeable membrane composed of polymer materials is easy to age. The drug res...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/52A61K9/16A61K31/137A61K47/36A61P11/08
Inventor 姜庆伟狄媛吕玉珠唐亚坤刘俊轶
Owner 北京天衡药物研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com